The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year

1996

Stage

Dead | Dead

Total Raised

$133.15M

About RealNames Corporation

RealNames Corporation is a Internet/Internet Software & Services company based in San Carlos, California. RealNames Corporation's investors include Draper Fisher Jurvetson, VeriSign, Clearstone Venture Partners, Bowman Capital Management, Morgan Stanley Venture Partners, Access Technology Partners, Chase H&Q, MSD Capital, Bayview Investors, Strong Capital Management, DWS Investments, Network Solutions, Munder Capital Management, Amerindo Investment Advisors, Peak Capital, J & W Seligman, Emigrant Capital, Seligman Investments, Goldman Sachs and Digital Island.

RealNames Corporation Headquarter Location

2 Circle Star Way 2nd Floor

San Carlos, California, 94070,

United States

650-298-8080

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest RealNames Corporation News

Keith Teare Joins MediChain as an Advisor – a Headline-Worthy News in the Blockchain ICO Market

Feb 13, 2018

All eyes are on MediChain now as Keith Teare, a globally-recognized serial entrepreneur with big ideas and an impressive record of winning high returns for the investors joins the MediChain Advisory Board. The recent addition of Teare in MediChain’s team is being seen as one of the greatest achievements of the company, since the executive chairman of Accelerated Digital Ventures has previously advised on the successful ICOBox, Crypterium, FluzFluz and EnergiMine ICOs. Stating his views about MediChain, Teare said, “Medichain represents a bold attempt to leverage the blockchain for patient records. It has long been recognized that patient-centric records represent a goal that would make health care far more efficient and enable doctors the benefit of seeing a patient’s entire medical history. Medichain is executing on that vision. Unlike others, it is also using machine learning to allow insights that can be gleaned from aggregate data. If it reaches its potential this will be a significant contribution to humanity.” About Keith Teare & His Successful Journey Keith is the co-founder of Archimedes Ventures where Mike Arrington’s TechCrunch was born and incubated along with Edgeio. He and Arrington were co-founders in both companies. Teare ran Edgeio and Arrington ran TechCrunch. He was the founder and CEO of RealNames Corporation and earlier the co-founder and CTO of EasyNet – the first European ISP. Working at RealNames, he created a multi-lingual naming system, with distinct national namespaces, sitting on top of the DNS. It used natural language keywords, mapped to URIs to allow native language navigation. Teare raised more than $130 million in venture funding and filed for an IPO in 1999. After negotiating a worldwide agreement to include RealNames in the Microsoft browser in early 2000, the company had an implied valuation of more than $1.5 billion. By 2002, it was responsible for over 1 billion keyword navigations per quarter. It had agreements in Japan, China, and Korea, and was responsible for supporting the nascent multi-lingual DNS system run by Verisign. He was the Seed funder and chair of NetNames, the founder of Clerkswell — a leading UK systems integrator as well as the Co-founder of CYBERIA, the world’s first Internet Café. Teare also served fotopedia being its founding board member. Keith Teare Foresees Blockchain as the Future of Most of the Industries Being a blockchain enthusiast and a start-up expert, Keith Teare strongly believes that moments of change represent the best time to invest in tech. His prediction is based on the fact that blockchain is going to be just everywhere in near future, and that’s what the transition in his professional journey shows: In 1981, he was focused on networking and shared data. In 1994, he initiated to harness the power of the Internet (EasyNet). In 1997, he turned to web services (RealNames). In 2005, his focus was on Web 2.0 (Archimedes Ventures, Edgeio, and TechCrunch). In 2010, he extensively worked on mobile (Archimedes Labs, Quixey, M.Dot). In 2018, he is all set to exploit the Blockchain (Accelerated Digital Ventures and MediChain). MediChain, leveraging the advisor-ship of Keith Teare, is planning ground-breaking developments on the platform in near future. To know more about MediChain and Keith Teare being its advisor, please visit https://medichain.online/ Disclaimer: The opinions expressed in this article do not represent the views of NewsBTC or any of its team members. NewsBTC is not responsible for the accuracy of any of the information supplied in Sponsored Stories/Press Releases such as this one. Subscribe to our newsletter

  • When was RealNames Corporation founded?

    RealNames Corporation was founded in 1996.

  • Where is RealNames Corporation's headquarters?

    RealNames Corporation's headquarters is located at 2 Circle Star Way, San Carlos.

  • What is RealNames Corporation's latest funding round?

    RealNames Corporation's latest funding round is Dead.

  • How much did RealNames Corporation raise?

    RealNames Corporation raised a total of $133.15M.

  • Who are the investors of RealNames Corporation?

    Investors of RealNames Corporation include Threshold Ventures, Bayview Investors, Access Technology Partners, Clearstone Venture Partners, Bowman Capital Management and 18 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.